Shire bid marks Takeda's latest - and biggest - push for global status
Read More
Bagikan Berita Ini
Rabu, 25 April 2018
News Business
Shire bid marks Takeda's latest - and biggest - push for global status
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd's $64 billion bid for London-listed rare disease specialist Shire Plc bolsters its credentials as Japan's most outward facing drugs firm, a mould-breaking image that has been more than a decade in the making.
Shire bid marks Takeda's latest - and biggest - push for global status
Read More
Bagikan Berita Ini
Shire bid marks Takeda's latest - and biggest - push for global status
Read More
Bagikan Berita Ini
0 Response to "Shire bid marks Takeda's latest - and biggest - push for global status"
Posting Komentar